| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |